|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/00 | (2006.01) |
| C12N 5/071 | (2010.01) | ||
| C12N 15/67 | (2006.01) | ||
| C12N 15/87 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 3536776 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19161388.4 |
| Date of filing the European patent application | 2015-04-29 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (30) | Number | Date | Country code |
| 201461985589 P | 2014-04-29 | US | |
| 201461994310 P | 2014-05-16 | US |
| (72) |
LAUX, Holger , CH
ROMAND, Sandrine , CH
BODENDORF, Ursula , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naujos stuburinių ląstelės ir metodai, skirti rekombinantinei dominančio polipeptido raiškai |
| NOVEL VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 12 | 289.00 EUR |
| 2027-04-29 |